First case report of erlotinib plus ramucirumab treatment for lung carcinosarcoma with EGFR L858R mutation.

Autor: Ishibashi, Naoya1 (AUTHOR) naoya1484@tohoku-mpu.ac.jp, Tabata, Toshiharu1 (AUTHOR), Nonomura, Ryo1 (AUTHOR), Oshima, Yutaka1 (AUTHOR), Sasaki, Takanobu1 (AUTHOR), Mitomo, Hideki1 (AUTHOR), Sugawara, Takafumi1 (AUTHOR), Sagawa, Motoyasu1 (AUTHOR)
Zdroj: Thoracic Cancer. Dec2023, Vol. 14 Issue 34, p3415-3418. 4p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje